Emerging role of novel therapies in Hodgkin lymphoma: proceed with caution

by Bartlett, Nancy L.
Published in Hematology Am Soc Hematol Educ Program (2017)

Approaches to aggressive B-cell lymphomas in less fit patients

by Bartlett, Nancy L.
Published in Hematology Am Soc Hematol Educ Program (2020)

Management of relapsed/refractory classical Hodgkin lymphoma in transplant-ineligible patients

by Mehta-Shah, Neha, Bartlett, Nancy L.
Published in Blood (2018)

(18)F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation

by Cashen, Amanda F., Dehdashti, Farrokh, Luo, Jingqin, Homb, Andrew, Siegel, Barry A., Bartlett, Nancy L.
Published 2011

Phase II Study of 9-aminocamptothecin in Previously Treated Lymphomas: Results of Cancer and Leukemia Group B 9551

by Bartlett, Nancy L., Johnson, Jeffrey L., Wagner-Johnston, Nina, Ratain, Mark J., Peterson, Bruce A.
Published in Cancer Chemother Pharmacol (2008)

High Incidence of Methotrexate Associated Renal Toxicity in Patients with Lymphoma: A Retrospective Analysis

by May, Jori, Carson, Kenneth R., Butler, Sara, Liu, Weijian, Bartlett, Nancy L., Wagner-Johnston, Nina D.
Published 2013

The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance)

by Smith, Sonali M., Schöder, Heiko, Johnson, Jeffrey L., Jung, Sin-Ho, Bartlett, Nancy L., Cheson, Bruce D.
Published in Leuk Lymphoma (2013)

Brentuximab Vedotin in Transplant-Naïve Patients with Relapsed or Refractory Hodgkin Lymphoma: Analysis of Two Phase I Studies

by Forero-Torres, Andres, Fanale, Michelle, Advani, Ranjana, Bartlett, Nancy L., Rosenblatt, Joseph D., Kennedy, Dana A., Younes, Anas
Published 2012

Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers

by Wildes, Tanya M., Farrington, Laura, Yeung, Cecilia, Harrington, Alexandra M., Foyil, Kelley V., Liu, Jingxia, Kreisel, Friederike, Bartlett, Nancy L., Fenske, Timothy S.
Published 2014

Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma

by Chen, Robert, Allibone, Suzanne, Bartlett, Nancy L, Brice, Pauline, Chen, Andy, Pose, Katrina, Rich, Lynn, Bonthapally, Vijay, Garfin, Phillip M, Fanale, Michelle
Published in Onco Targets Ther (2016)

Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)

by Wagner-Johnston, Nina D., Link, Brian K., Byrtek, Michelle, Dawson, Keith L., Hainsworth, John, Flowers, Christopher R., Friedberg, Jonathan W., Bartlett, Nancy L.
Published in Blood (2015)

Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: Final results of a phase II trial (CALGB 50501)

by Morrison, Vicki A., Jung, Sin-Ho, Johnson, Jeffrey, LaCasce, Ann, Blum, Kristie A., Bartlett, Nancy L., Pitcher, Brandelyn N., Cheson, Bruce D.
Published in Leuk Lymphoma (2014)

Increased Body Mass Index Is Associated With Improved Survival in United States Veterans With Diffuse Large B-Cell Lymphoma

by Carson, Kenneth R., Bartlett, Nancy L., McDonald, Jay R., Luo, Suhong, Zeringue, Angelique, Liu, Jingxia, Fu, Qiang, Chang, Su-Hsin, Colditz, Graham A.
Published 2012

Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance)

by Leonard, John P., Jung, Sin-Ho, Johnson, Jeffrey, Pitcher, Brandelyn N., Bartlett, Nancy L., Blum, Kristie A., Czuczman, Myron, Giguere, Jeffrey K., Cheson, Bruce D.
Published in J Clin Oncol (2015)

Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin

by Horwitz, Steven M., Advani, Ranjana H., Bartlett, Nancy L., Jacobsen, Eric D., Sharman, Jeff P., O’Connor, Owen A., Siddiqi, Tanya, Kennedy, Dana A., Oki, Yasuhiro
Published in Blood (2014)

A pilot study of lenalidomide maintenance therapy after autologous transplantation in relapsed or refractory classical Hodgkin lymphoma

by Shea, Lauren, Watkins, Marcus P., Wan, Fei, Cashen, Amanda, Wagner-Johnston, Nina, Jacoby, Meagan, Abboud, Camille, Dipersio, John, Hurd, David, Jaglowski, Samantha, Bartlett, Nancy L., Fehniger, Todd
Published in Biol Blood Marrow Transplant (2020)

Assessment of Cellular Proliferation in Tumors by PET Using (18)F-ISO-1

by Dehdashti, Farrokh, Laforest, Richard, Gao, Feng, Shoghi, Kooresh I., Aft, Rebecca L., Nussenbaum, Brian, Kreisel, Friederike H., Bartlett, Nancy L., Cashen, Amanda, Wagner-Johnson, Nina, Mach, Robert H.
Published 2013

Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)

by Rosenbaum, Cara A., Jung, Sin-Ho, Pitcher, Brandelyn, Bartlett, Nancy L., Smith, Sonali M., Hsi, Eric, Wagner-Johnston, Nina, Thomas, Sachdev P., Leonard, John P., Cheson, Bruce D.
Published in Br J Haematol (2019)

Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory, Indolent B-cell Non-Hodgkin Lymphoma: Results From a Multicenter Study

by Kahl, Brad S., Bartlett, Nancy L., Leonard, John P., Chen, Ling, Ganjoo, Kristen, Williams, Michael E., Czuczman, Myron S., Robinson, K. Sue, Joyce, Robin, van der Jagt, Richard H., Cheson, Bruce D.
Published 2010

Interim FDG PET Imaging in Stage I/II Non-Bulky Hodgkin Lymphoma: Would using combined PET and CT criteria better predict response than each test alone?

by Kostakoglu, Lale, Schöder, Heiko, Johnson, Jeffrey L., Hall, Nathan C., Schwartz, Lawrence H., Straus, David J., LaCasce, Ann S., Jung, Sin-Ho, Bartlett, Nancy L., Canellos, George P., Cheson, Bruce D.
Published in Leuk Lymphoma (2012)